Big shares of a losing biotech stock didn’t stop a pair of four-star-rated ETFs from moving higher Thursday. They may sound similar, but hold distinct investments once you look under the hood.
Biogen and Moderna shares show how biotech ETFs may look similar but act differently
Leave a reply
Foreaders 